NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells-Reference-Cited by-同舟云学术

NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells

Published:2019-05 Issue:21 Volume:294 Page:8543-8554
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Farah Elia,Li Chaohao,Cheng Lijun,Kong Yifan^ORCID,Lanman Nadia A.^ORCID,Pascuzzi Pete^ORCID,Lorenz Gabrielle Renee,Zhang Yanquan,Ahmad Nihal,Li Lang,Ratliff Tim,Liu Xiaoqi

Funder

Foundation for the National Institutes of Health (FNIH)

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference36 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin,2017

2. Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents;Bahl;Cancer Treat. Rev,2014

3. Effect of visceral disease site on outcomes in patients with metastatic castration-resistant prostate cancer treated with enzalutamide in the PREVAIL trial;Alumkal;Clin. Genitourin. Cancer,2015

4. Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone;Bianchini;Eur. J. Cancer,2014

5. A novel antiandrogen, compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivo;Kuruma;Mol. Cancer Ther,2013

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of prostate cancer associated genes for diagnosis and prognosis: a modernized in silico approach;Mammalian Genome;2024-08-17

2. Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer;Journal of Clinical Investigation;2024-07-18

3. Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach;Biomolecules;2024-01-10

4. Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC;Nature Communications;2024-01-08

5. Genomic Portraits: Reflections into a Tumor's Response to Therapy;Clinical Cancer Research;2023-08-30